$3.51
▲ +14.7% Today
as of Oct 23, 11:49 ET
Last 30 days
Recent Press Releases & News
Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
Nasus Pharma Announces FDA Clearance to Initiate Clinical Study of NS002 in the Treatment of Anaphylaxis
Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
NSRX earnings at a glance
The share price of $3.51 sits in the middle of its 52-week range.
Overview
52-week range
$1.98
$9.50
20% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for NSRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.